DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A*0201 mice

Vaccine

Volumn 23, Issue 6, 2004, Pages 819-826

  Gallez Hawkins, Ghislaine ^a   Li, Xiuli ^a   Franck, Anne E ^a   Thao, Lia ^a   Lacey, Simon F ^a   Diamond, Don J ^a   Zaia, John A ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Cytomegalovirus; Immunization; RAAV

Indexed keywords

ANTIBODY; CD8 ANTIGEN; DNA VACCINE; EPITOPE; HLA A ANTIGEN; IMMEDIATE EARLY 1 PROTEIN; IMMEDIATE EARLY PROTEIN; PEPTIDE; PROTEIN PP65; TETRAMER; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BINDING AFFINITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; DRUG PROTEIN BINDING; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TECHNOLOGY; TITRIMETRY; TRANSGENIC MOUSE; VACCINATION; VIRUS RECOMBINANT;

ANIMALS; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS VACCINES; DEPENDOVIRUS; HLA ANTIGENS; IMMEDIATE-EARLY PROTEINS; MICE; MICE, TRANSGENIC; PHOSPHOPROTEINS; VACCINES, SYNTHETIC; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

EID: 8144227002     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.06.048     Document Type: Article

References (41)

1. A. Henke DNA immunization - a new chance in vaccine research Med. Microbiol. Immunol. (Berl.) 191 3-4 2002 187 190
2. M. Palmowski, M. Salio, R.P. Dunbar, and V. Cerundolo The use of HLA class I tetramers to design a vaccination strategy for melanoma patients Immunol. Rev. 188 2002 155 163
3. H. Herweijer, and J.A. Wolff Progress and prospects: naked DNA gene transfer and therapy Gene Ther. 10 6 2003 453 458
4. W.P. Cheevers, K.R. Snekvik, J.D. Trujillo, N.M. Kumpula-McWhirter, K.J. Pretty On Top, and D.P. Knowles Prime-boost vaccination with plasmid DNA encoding caprine-arthritis encephalitis lentivirus env and viral SU suppresses challenge virus and development of arthritis Virology 306 1 2003 116 125
5. P. Pancholi, M. Perkus, N. Tricoche, Q. Liu, and A.M. Prince DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice J. Virol. 77 1 2003 382 390
6. C.A. Meseda, K.L. Elkins, M.J. Merchlinsky, and J.P. Weir Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone J. Infect Dis. 186 8 2002 1065 1073
7. J.Y. Su, S. Chatterjee, and K.K. Wong Jr. Immunogenic issues concerning recombinant adeno-associated virus vectors for gene therapy Curr. Gene Ther. 2 4 2002 485 500
8. K.K. Wong Jr., and S. Chatterjee Adeno-associated virus based vectors as antivirals Curr. Top Microbiol. Immunol. 218 1996 145 170
9. P.J. Carter, and R.J. Samulski Adeno-associated viral vectors as gene delivery vehicles Int. J. Mol. Med. 6 1 2000 17 27
10. A.K. Zaiss, Q. Liu, G.P. Bowen, N.C. Wong, J.S. Bartlett, and D.A. Muruve Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors J. Virol. 76 9 2002 4580 4590
11. D.G. Brockstedt, G.M. Podsakoff, L. Fong, G. Kurtzman, W. Mueller-Ruchholtz, and E.G. Engleman Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration Clin. Immunol. 92 1 1999 67 75
12. Y. Hamel, N. Blake, S. Gabrielsson, T. Haigh, K. Jooss, and C. Martinache Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy Hum. Gene Ther. 13 7 2002 855 866
13. W.C. Manning, X. Paliard, S. Zhou, M. Pat Bland, A.Y. Lee, and K. Hong Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D J. Virol. 71 10 1997 7960 7962
14. D.W. Liu, Y.P. Tsao, J.T. Kung, Y.A. Ding, H.K. Sytwu, and X. Xiao Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer J. Virol. 74 6 2000 2888 2894
15. K.Q. Xin, M. Urabe, J. Yang, K. Nomiyama, H. Mizukami, and K. Hamajima A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus Hum. Gene Ther. 12 9 2001 1047 1061
16. G. Gallez-Hawkins, M.C. Villacres, X. Li, M.C. Sanborn, N.A. Lomeli, and J.A. Zaia Use of transgenic HLA A*0201/Kb and HHDII mice to evaluate frequency of cytomegalovirus IE1-derived peptide usage in eliciting human CD8 cytokine response J. Virol. 77 7 2003 4457 4462
17. A. Akrigg, G.W. Wilkinson, and J.D. Oram The structure of the major immediate early gene of human cytomegalovirus strain AD169 Virus Res. 2 2 1985 107 121
18. Z.Q. Yao, G. Gallez-Hawkins, N.A. Lomeli, X. Li, K.M. Molinder, and D.J. Diamond Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting Vaccine 19 13-14 2001 1628 1635
19. G. Gallez-Hawkins, N.A. Lomeli, X. Li, Z.Q. Yao, C. La Rosa, and D.J. Diamond Kinase-deficient CMVpp65 triggers a CMVpp65 specific T-cell immune response in HLA-A*0201.Kb transgenic mice after DNA immunization Scand. J. Immunol. 55 6 2002 592 598
20. L. Drittanti, C. Jenny, K. Poulard, A. Samba, P. Manceau, and N. Soria Optimised helper virus-free production of high-quality adeno-associated virus vectors J. Gene Med. 3 1 2001 59 71
21. S. Chatterjee, P.R. Johnson, and K.K. Wong Jr. Dual-target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector Science 258 5087 1992 1485 1488
22. L. BenMohamed, R. Krishnan, J. Longmate, C. Auge, L. Low, and J. Primus Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response Hum. Immunol. 61 8 2000 764 779
23. H. Firat, F. Garcia-Pons, S. Tourdot, S. Pascolo, A. Scardino, and Z. Garcia H-2 class I knockout HLA-A2. 1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies Eur. J. Immunol. 29 10 1999 3112 3121
24. V. Endresz, L. Kari, K. Berencsi, C. Kari, Z. Gyulai, and C. Jenev Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization Vaccine 17 1 1999 50 58
25. + T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants Transplantation 74 5 2002 722 732
26. I.E. Alexander, D.W. Russell, and A.D. Miller Transfer of contaminants in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results Hum. Gene Ther. 8 16 1997 1911 1920
27. R.J. Samulski, L.S. Chang, and T. Shenk Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression J. Virol. 63 9 1989 3822 3828
28. C.S. Manno, A.J. Chew, S. Hutchison, P.J. Larson, R.W. Herzog, and V.R. Arruda AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B Blood 101 8 2003 2963 2972
29. D.W. Russell, I.E. Alexander, and A.D. Miller DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors Proc. Natl. Acad. Sci. U.S.A. 92 12 1995 5719 5723
30. I.E. Alexander, D.W. Russell, and A.D. Miller DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors J. Virol. 68 12 1994 8282 8287
31. J.W. Shiver, T.M. Fu, L. Chen, D.R. Casimiro, M.E. Davies, and R.K. Evans Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature 415 6869 2002 331 335
32. D. Huser, S. Weger, and R. Heilbronn Packaging of human chromosome 19-specific adeno-associated virus (AAV) integration sites in AAV virions during AAV wild-type and recombinant AAV vector production J. Virol. 77 8 2003 4881 4887
33. C.L. Halbert, E.A. Rutledge, J.M. Allen, D.W. Russell, and A.D. Miller Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes J. Virol. 74 3 2000 1524 1532
34. C.L. Halbert, T.A. Standaert, C.B. Wilson, and A.D. Miller Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure J. Virol. 72 12 1998 9795 9805
35. M. Hildinger, A. Auricchio, G. Gao, L. Wang, N. Chirmule, and J.M. Wilson Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer J. Virol. 75 13 2001 6199 6203
36. W.C. Manning, S. Zhou, M.P. Bland, J.A. Escobedo, and V. Dwarki Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors Hum. Gene Ther. 9 4 1998 477 485
37. M. Moskalenko, L. Chen, M. van Roey, B.A. Donahue, R.O. Snyder, and J.G. McArthur Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure J. Virol. 74 4 2000 1761 1766
38. M.E. Bloom, and N.S. Young Parvoviruses D.M. Knipe P.M. Howley Fields' Virology-4th 2001 Lippincott Williams & Wilkins Philadelphia 2373 2374
39. J.E. Rabinowitz, F. Rolling, C. Li, H. Conrath, W. Xiao, and X. Xiao Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity J. Virol. 76 2 2002 791 801
40. H. Chao, P.E. Monahan, Y. Liu, R.J. Samulski, and C.E. Walsh Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vectors Mol. Ther. 4 3 2001 217 222
41. W. Xiao, N. Chirmule, S.C. Berta, B. McCullough, G. Gao, and J.M. Wilson Gene therapy vectors based on adeno-associated virus type 1 J. Virol. 73 5 1999 3994 4003